Pulse Biosciences Inc (PLSE) Stock Analysis
Verdict: AVOID
A $3.5B valuation on $0.35M revenue creates extreme dilution risk as an $85M ATM offering offsets clinical progress in nsPFA technology.
Investment score: 36/100
Analysis as of
Is Pulse Biosciences Inc stock worth reviewing? AI model thesis
The AI model assigns an AVOID rating on PLSE due to astronomical valuation multiples (P/S 2,897x vs peer median ~4.5x), near-term dilution risk from a fresh $85M ATM shelf, and an 18-month cash runway.
7-factor investment score
- Valuation: 10/100 (weight 20%)
- Financial Health: 25/100 (weight 15%)
- Technical Momentum: 60/100 (weight 15%)
- Earnings Quality: 55/100 (weight 15%)
- Insider Sentiment: 60/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 20/100 (weight 15%)
Pulse Biosciences Inc opportunities and risks
What speaks for PLSE
- Proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology platform
What speaks against PLSE
- Immediate equity dilution risk from $85M At-The-Market (ATM) stock offering
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| PLSE | n/a | 2897.5x | n/a | -21.6% | -6755.8% | -1.8% |
| ITGR | 34.2x | 2.3x | 18.0x | 23.7% | 7.0% | 2.6% |
| NVST | 42.3x | 1.4x | 11.6x | 55.5% | 3.3% | 5.7% |
| IRTC | n/a | 4.5x | 206.7x | 71.5% | -1.7% | 1.1% |
| TMDX | 19.8x | 4.5x | 28.5x | 58.7% | 22.7% | 2.6% |
| ATRC | 269.3x | 5.1x | 103.5x | 76.2% | 1.9% | 2.0% |
| Peer median | 34.2x | 4.5x | 28.5x | 58.7% | 3.3% | 2.6% |
Frequently asked questions about Pulse Biosciences Inc (PLSE)
Is PLSE stock a good investment?
The cached TradeMates AI model rates Pulse Biosciences Inc as AVOID with an investment score of 36/100. The AI model assigns an AVOID rating on PLSE due to astronomical valuation multiples (P/S 2,897x vs peer median ~4.5x), near-term dilution risk from a fresh $85M ATM shelf, and an 18-month cash runway. This is algorithmic model output, not personal investment advice.
Is PLSE stock a buy?
The TradeMates model verdict for PLSE is AVOID with an investment score of 36/100. Treat this as a model signal to review, not a personal buy recommendation.